Amylin, Lilly Address FDA Alert for Byetta-September 2008

In an effort to clear up any confusion and provide context on the FDA's alert for the diabetes drug Byetta, the companies marketing the medication recently held a conference call.

Amylin Pharmaceuticals Inc and Eli Lilly and Co, which comarket the diabetes drug Byetta (exenatide) for injection, held a conference call August 26 to clear up any confusion regarding Byetta and pancreatitis. The companies held the conference call following the FDA’s August 18 update to a prior alert for the drug.

“Since last week’s FDA alert, it was apparent there was a lot of confusion,” said Daniel Bradbury, Amylin president and chief executive. “As a result, in this particular incidence, we felt a broad communication was warranted to provide greater context and clarity about the FDA posting.”

“It is important to understand that pancreatitis…is a rare event. Further, the characteristics and complications of the pancreatitis cases in patients on Byetta are consistent with pancreatitis in the general population. We believe Byetta continues to have a positive benefit-risk profile for patients with type 2 diabetes,” said Orville G. Kolterman, senior vice president for research and development at Amylin.

The August 18 alert referenced 6 cases of hemorrhagic or necrotizing pancreatitis, which were associated with 2 deaths. In the other 4 cases, the causes of death did not appear attributable to pancreatitis. The companies said they were aware of the pancreatitis cases referenced in the alert, as well as others, and previously reported these cases to the FDA.

Since 2006, the US prescribing information for Byetta has included information about pancreatitis. In 2007, after discussions with the FDA, the companies amended the prescribing information to include pancreatitis as a “precaution.” The US patient package insert also was updated at that time. The Byetta patient Web site also has been updated to include answers to frequently asked questions regarding the most recent FDA announcements.

Related Videos
Senior Male Research Scientist is Using a Tablet Computer in a Modern High-Tech Laboratory. Genetics and Pharmaceutical Studies and Researches | Image Credit: Gorodenkoff - stock.adobe.com
Acute psoriasis on the elbows is an autoimmune incurable dermatological skin disease. Large red, inflamed, flaky rash on the knees. Joints affected by psoriatic arthritis | Image Credit: SNAB - stock.adobe.com
Portrait of a smiling female pharmacist, male colleague working with drugs in the background. | Image Credit: bnenin - stock.adobe.com
Dermatologist examining the skin of a patient | Image Credit: thodonal - stock.adobe.com
Burnout illustration | Image credit: Vikky Mir - stock.adobe.com
Public Health Matters podcast logo
© 2023 MJH Life Sciences

All rights reserved.